Hyperlipidemias Completed Phase 4 Trials for Rosuvastatin (DB01098)

Also known as: Hyperlipidemia / Hyperlipemia / Hyperlipidaemia / Hyperlipaemia / Hyperlipidemia, unspecified / Lipidemia / Hyperlipidaemia NOS

IndicationStatusPhase
DBCOND0031916 (Hyperlipidemias)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117494Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)Treatment
NCT00473655Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic PatientsTreatment
NCT01023607Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)Treatment
NCT01414803Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined HyperlipidemiaTreatment
NCT02280590Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With HyperlipidemiaTreatment